Bristlecone Advisors LLC increased its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 9.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,945 shares of the pharmacy operator’s stock after purchasing an additional 828 shares during the period. Bristlecone Advisors LLC’s holdings in CVS Health were worth $587,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Riverpoint Wealth Management Holdings LLC acquired a new stake in shares of CVS Health in the 4th quarter valued at approximately $218,000. Canoe Financial LP increased its stake in CVS Health by 95.1% in the fourth quarter. Canoe Financial LP now owns 1,762,629 shares of the pharmacy operator’s stock valued at $139,177,000 after purchasing an additional 859,134 shares in the last quarter. Steph & Co. raised its holdings in CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the period. Forum Financial Management LP grew its holdings in shares of CVS Health by 19.4% in the 4th quarter. Forum Financial Management LP now owns 17,856 shares of the pharmacy operator’s stock valued at $1,410,000 after buying an additional 2,901 shares during the period. Finally, Douglas Lane & Associates LLC increased its position in shares of CVS Health by 1.6% in the 1st quarter. Douglas Lane & Associates LLC now owns 1,084,256 shares of the pharmacy operator’s stock valued at $86,480,000 after buying an additional 16,840 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.
Analysts Set New Price Targets
Several research firms have weighed in on CVS. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Monday, August 19th. Barclays lowered their target price on CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, August 8th. Leerink Partnrs lowered shares of CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. The Goldman Sachs Group lowered their price objective on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Finally, UBS Group lowered shares of CVS Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $85.00 to $60.00 in a research note on Thursday, May 2nd. Eleven equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $73.24.
CVS Health Stock Performance
Shares of CVS traded down $0.01 during midday trading on Monday, reaching $58.74. The stock had a trading volume of 3,794,205 shares, compared to its average volume of 11,242,852. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The firm has a 50 day simple moving average of $58.86 and a 200-day simple moving average of $65.01. The firm has a market cap of $73.74 billion, a PE ratio of 10.37, a P/E/G ratio of 0.57 and a beta of 0.52. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25.
CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter in the previous year, the business earned $2.21 earnings per share. The business’s revenue was up 2.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that CVS Health Co. will post 7 EPS for the current year.
CVS Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.53%. CVS Health’s dividend payout ratio is currently 46.75%.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
- Five stocks we like better than CVS Health
- What is the S&P 500 and How It is Distinct from Other Indexes
- Why the Buy-and-Hold Strategy May Be Best for Most Investors
- 3 Fintech Stocks With Good 2021 Prospects
- Eli Lilly’s Path to the Next Trillion Market Capitalization
- The 3 Best Blue-Chip Stocks to Buy Now
- Mobileye Global: CEO Makes $10 Million Bet on Future Strength
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.